Dateline City:
MADISON, N.J.
First Vaccine to Offer Protection Against Both Strains of Canine Influenza
MADISON, N.J.--(BUSINESS WIRE)--Merck Animal Health, known as MSD Animal Health outside of the United
States and Canada, today announced that the U.S. Department of
Agriculture has approved a license for Nobivac Canine Flu
Bivalent vaccine the first vaccine to aid in the control of disease
associated with both canine influenza virus (CIV) H3N2 and canine
influenza virus H3N8.
Language:
English
Contact:
MerckMedia:Kelly Goss, 913-558-6452 kelly.goss@merck.com orPamela Eisele, 267-305-3558 pamela.eisele@merck.com orInvestor Relations:Amy Klug, 908-740-1898 amy.klug@merck.com
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more